Ensemble Health Plans $13 Billion Sale or IPO, Partners with JPMorgan for 2026 Market Entry

Ensemble Health, specializing in healthcare revenue management, is preparing for a potential sale or IPO targeting a $13 billion valuation. According to sources, the company aims to enter the market early next year and has enlisted JPMorgan to guide the process.